Histogen Inc. (NASDAQ: HSTO) is -81.05% lower on its value in year-to-date trading and has touched a low of $0.96 and a high of $7.50 in the current 52-week trading range. The HSTO stock was last observed hovering at around $1.04 in the last trading session, with the day’s loss setting it -0.28% off its average median price target of $15.00 for the next 12 months. It is also 94.93% off the consensus price target high of $15.00 offered by 1 analysts, but current levels are 94.93% higher than the price target low of $15.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $0.76, the stock is -36.68% and -49.27% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 16.16 million and changing -27.12% at the moment leaves the stock -72.30% off its SMA200. HSTO registered -80.71% loss for a year compared to 6-month loss of -78.83%. The firm has a 50-day simple moving average (SMA 50) of $1.3003 and a 200-day simple moving average (SMA200) of $2.1480.
The stock witnessed a -42.14% gain in the last 1 month and extending the period to 3 months gives it a -51.10%, and is -32.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.54% over the week and 9.64% over the month.
Histogen Inc. (HSTO) has around 5 employees, a market worth around $15.60M and $2.10M in sales. Distance from 52-week low is -21.45% and -89.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-59.40%).
Histogen Inc. (HSTO) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Histogen Inc. (HSTO) is a “Hold”. 1 analysts offering their recommendations for the stock have an average rating of 3.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Histogen Inc. quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $526k over the same period.The EPS is expected to grow by 42.10% this year, but quarterly earnings will post -35.30% year-over-year. Quarterly sales are estimated to shrink -92.90% in year-over-year returns.
Histogen Inc. (HSTO) Top Institutional Holders
20 institutions hold shares in Histogen Inc. (HSTO), with 4M shares held by insiders accounting for 31.98% while institutional investors hold 5.74% of the company’s shares. The shares outstanding are 12.17M, and float is at 10.21M with Short Float at 0.73%. Institutions hold 3.90% of the Float.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 0.12 million shares valued at $0.2 million. The investor’s holdings represent 0.99% of the HSTO Shares outstanding. As of Sep 29, 2020, the second largest holder is Renaissance Technologies, LLC with 0.11 million shares valued at $0.17 million to account for 0.85% of the shares outstanding. The other top investors are Acadian Asset Management which holds 81827.0 shares representing 0.65% and valued at over $0.13 million, while United Capital Financial Advisers, LLC holds 0.65% of the shares totaling 80747.0 with a market value of $0.13 million.
Histogen Inc. (HSTO) Insider Activity
The most recent transaction is an insider purchase by Pascoe Richard W, the company’s President, CEO & Director. SEC filings show that Pascoe Richard W bought 10,000 shares of the company’s common stock on Dec 03 at a price of $1.24 per share for a total of $12394.0. Following the purchase, the insider now owns 10000.0 shares.